PharmaCielo Ltd (PCLOF)
0.1408
-0.03
(-16.43%)
USD |
OTCM |
May 31, 16:00
PharmaCielo Profit Margin (Quarterly): -784.9% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -784.9% |
| June 30, 2023 | -2.25K% |
| March 31, 2023 | -452.6% |
| December 31, 2022 | -192.6% |
| September 30, 2022 | -1.09K% |
| June 30, 2022 | -166.0% |
| March 31, 2022 | -242.4% |
| December 31, 2021 | -1.21K% |
| September 30, 2021 | -1.80K% |
| Date | Value |
|---|---|
| June 30, 2021 | -1.62K% |
| March 31, 2021 | -968.8% |
| December 31, 2020 | -2.26K% |
| September 30, 2020 | -37.80K% |
| June 30, 2020 | -626.3% |
| March 31, 2020 | -1.23K% |
| December 31, 2019 | -1.89K% |
| September 30, 2019 | -2.94K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-37.80K%
Minimum
Sep 2020
-166.0%
Maximum
Jun 2022
-3.38K%
Average
-1.21K%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | -146.9% |
| Venus Concept Inc | -56.03% |
| Juva Life Inc | -85.00% |
| Lucy Scientific Discovery Inc | -27.05K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -245.0% |
| Return on Assets | -49.42% |
| Return on Invested Capital | -67.08% |
| Gross Profit Margin (Quarterly) | -99.29% |
| Operating Margin (Quarterly) | -663.0% |
| Return on Net Operating Assets | -50.54% |